FDA accepts Regeneron's sBLA for Eylea HD in RVO with priority review; QUASAR data supports monthly dosing, target action date set for August 2025.

Canaccord analyst John Newman lowered the firm’s price target on Regeneron (REGN) to $150 from $170 and keeps a Hold rating on the shares. The ...

The stock's fall snapped a two-day winning streak.

This agreement enables the company to launch in the US in the second half of calendar year 2026 or earlier in certain circumstances ...

Biocon Biologics on Tuesday said it has inked a settlement and licensing pact with Regeneron, paving the way to commercialise its biosimilar product Yesafili in the US.

BENGALURU: Biopharmaceutical company Biocon's share price on Tuesday jumped over 4 per cent after its subsidiary Biocon ...

The Hankinson Public School Science Fair team once again demonstrated their remarkable dedication, creativity, and perseverance during the 2025 North Dakota State Science and Engineering Fair.

Eighteen-year-old Matteo Paz has stunned the scientific community by using AI and machine learning to identify 1.5 million ...

Even as Donald Trump paused the reciprocal tariffs for 90 days, he later confirmed that pharmaceutical companies would face ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Auburn University and the I-Stem Connectory at AU hosted the 2025 Alabama Science and Engineering Fair on Saturday, April 5.